In this study, we identified the mitochondrial damage effects of OPA1 in AD; however, OPA1 undergoes alternative splicing to generate long (L-OPA1) and short (S-OPA1) isoforms, which exert distinct functional mechanisms. Here, OPA1 is linked to Alzheimer disease.